Conditions: Schizophrenia
Keywords: Quetiapine efficacy in schizophrenia
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 28
Healthy volunteers: yes

Brief summary:
The purpose of this study is to evaluate the efficacy of Seroquel XR in schizophrenia patients with acute worsening symptoms. Consequently, to assess whether the study drug is safe and acceptable on the daily dose basis, orally given, up to 600 mg once a day for 42 days.

Detailed description:

Arms:

Interventions: intervention 1: Quetiapine fumarate (Seroquel)
Intervention descriptions: intervention 1: 600mg Extended release tablet, oral, once daily

Protocol document: